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Objective: One of the early hallmarks of osteoarthritis (OA) is a progressive degeneration of 
the articular cartilage. Early diagnosis of OA-associated cartilage alterations would be 
beneficial for disease prevention and control, and for the development of disease-modifying 
treatments. However, early diagnosis is still hampered by a lack of quantifiable readouts in 
preclinical models. Design: In this study, we have shown the potency of contrast-enhanced 
nanofocus X-ray computed tomography (CE-nanoCT) to be used for virtual 3D 
histopathology in established mouse models for OA, and we compared with standard 
histopathology. Results: We showed the equivalence of CE-nanoCT images to histopathology 
for the modified Mankin scoring of the cartilage structure and quality. Additionally, a limited 
set of 3D cartilage characteristics measured by CE-nanoCT image analysis in a user-
independent and semi-automatic manner, i.e. average and maximum of the non-calcified 
cartilage thickness distribution and loss in glycosaminoglycans, was shown to be predictive 
for the cartilage quality and structure as can be evaluated by histopathological scoring through 
the use of an empirical model. Conclusions: We have shown that CE-nanoCT is a tool that 
allows virtual histopathology as well as 3D morphological quantification of multi-tissue 
systems, such as the chondro-osseous junction. It provides faster and more quantitative data 
on cartilage structure and quality compared to standard histopathology while eliminating user-
5 
 
bias. CE-nanoCT thus should allow capturing subtle differences in cartilage characteristics, 
carefully mapping OA progression and, ultimately, asses the beneficial changes when testing 
a candidate disease-modifying treatment. 
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histopathology, modified Mankin scoring, 3D cartilage quantification 
 
Introduction 
Musculoskeletal diseases are a major burden on individuals, health systems and resources. 
They are the most common cause of severe long-term pain and physical disability, and affect 
hundreds of millions of people‟s quality of life all around the world. Osteoarthritis (OA), a 
progressive, degenerative disease of the (articular) joints (hips, knees, neck, lower back, or 
small joints of the hands), represents the most common musculoskeletal disease. The etiology 
of the disease is not well understood and OA is considered a complex disease to which both 
genetic and acquired or environmental factors contribute
[1]
. Misalignment of the joint and 
joint instability resulting from (untreated) cartilage defects, previous surgery (e.g. partial or 
total meniscectomy) or from other traumas and injuries to the joint, as well as intensive 




OA affects all structures within the joint, but an early hallmark is a progressive degeneration 
of the articular cartilage accompanied by bony remodeling (subchondral bone sclerosis and 
osteophyte formation), occasional flares of inflammation, mild synovitis (in some patients) 
and osteitis. OA affects the joint in a non-uniform and focal manner. Localized loss of 
cartilage can increase focal stress across the joint leading to further cartilage destruction. This 
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then eventually results in a misalignment and destabilization of the whole joint and 
progression and aggravation of the disease. Early diagnosis of OA-associated cartilage 
alterations would be very beneficial for disease prevention and control, not at the least 
because current treatment of established OA is symptomatic and palliative with an emphasis 
on control of joint pain and maintenance of function. The lack of a cure and associated huge 
unmet medical need provide an opportunity for the development of novel approaches and 
medicines to treat OA, especially for disease-modifying therapies that can halt and/or reverse 
the onset and progression of the disease. However, the development of therapeutic approaches 
is largely hampered by the lack of quantifiable readouts in preclinical models. Refinement and 
validation of the readout technology for OA biology would be tremendously valuable for the 
animal studies on joint degeneration, and should allow us capturing subtle differences and 
thus broader hallmarks of the disease, carefully map the disease progression in the different 
tissues and animal models and, ultimately, asses the beneficial changes of those hallmarks 
when testing the candidate disease-modifying treatment 
[4]
.  
Currently, preclinical efficacy of novel therapies for cartilage repair in small animal models 
is commonly assessed by histopathology
[5-7]
. The modified Mankin scoring system
[6, 8, 9]
 is 
often used for semi-quantitative histological assessment of OA due to its already widespread 
adoption, ease of use and its similarity to scoring systems used for OA in humans
[10]
. This 
method focuses amongst others on the structural changes observed, such as lesions or 
ﬁbrillations and losses in proteoglycan (PG) staining. Histopathology has a high 
discriminative power but is destructive, labor intensive, costly in terms of time and resources, 
and, in standard settings it only provides 2D information because of the loss of data by the 
thickness of the sections, thus spatial and quantitative 3D assessment of the cartilage structure 
and quality are not feasible. Additionally, the modified Mankin scoring is currently not 
annotated automatically, with consequent inter-reader variability. The said limitations prompt 
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the current need for a 3D imaging technique that is able to quantify the cartilage properties in 




Recent advances in 3D imaging techniques, such as high-resolution microfocus X-ray 
computed tomography (microCT) imaging, have led to successful quantification of the  
changes in the subchondral bone structure in the mouse knee joint during the progression of 
OA
[5, 7]
. The use of ionic partition equilibrium contrast agents, such as anionic (i.e. 
Hexabrix®)
[12-16]
 or cationic contrast agents
[17]
, as well as lead-based contrast agents
[18]
 have 
shown to allow quantification of functional and structural information of the cartilage. 
However, the limited spatial image resolution of most microCT devices does not allow to 





 readouts refrain to show equivalence to 
standard histopathological scorings
[15, 18, 19]
. Moreover, although several 3D cartilage 
characteristics were quantified, no validation compared to the golden standard of 
histopathological scoring was performed yet.  
In a previous study
[20]
, we evaluated the potency of contrast-enhanced nanofocus X-ray 
computed tomography (CE-nanoCT) to simultaneously image in 3D the subtissue architecture 
of cartilage at high contrast and spatial image resolution without invasive, labor-intensive 
sample preparation. In this study, we have shown, in an established mouse model for OA
[21]
, 
that CE-nanoCT can be used as an imaging tool for virtual 3D histopathology. By direct 
comparison with standard histopathology we showed equivalence of CE-nanoCT images for 
the scoring of the structure, quality and pathophysiology of the chondro-osseous junction. 
Additionally, the quantitative nature of the 3D CE-nanoCT datasets allowed to develop an 
empirical model based on a limited set of 3D cartilage characteristics measured by 3D image 
analysis, which, is predictive for the cartilage quality and structure as can be evaluated by 
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histopathological scoring. This model thus could be a potential replacement of or 
complimentary tool for the modified Mankin scoring when assessing preclinical efficacy of 
novel therapies for cartilage repair. 
 
Materials and methods 
Mouse model 
Destabilization of the medial meniscus (DMM) by medial meniscotibial ligament transection 
leads to mild OA with various degrees of cartilage lesions
[21]
. To show the potential of CE-
nanoCT for virtual histopathology and 3D quantification of cartilage characteristics, four 





) mice that were sham operated (Sham), or that underwent a medial meniscus 
destabilization procedure and were sacrificed 8 weeks later. As a third group (DMM/HA), 
right knee joints were harvested after 8 weeks from mice that underwent a DMM procedure, 
and were injected after 2 and 5 weeks with hyaluronic acid, which is in clinical use as visco-
supplementation treatment. A final group contained age-matched non-surgical controls (AM). 
We have worked with the nude mouse model to assess the effect of DMM on the cartilage 
structure and quality, because it allows testing a cellular therapy in the mouse using human 
cells (ongoing work).  
These four research-relevant groups were selected to obtain a broad spectrum of cartilage 
defects on a per-animal basis (i.e. from bad to unaffected) that one might encounter in 
preclinical OA research, thus to show the potency of CE-nanoCT to be implemented as a 
standard technique in the OA field rather than to interpret the biology behind DMM-induced 
OA. All knee joints were imaged using CE-nanoCT, after which some were randomly 
sampled to allow a comparison to the histological gold standard. 
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Animal experiments were performed in accordance with the Belgian legislation under the 
national authorization number LA1210530 and were approved by the Ethical Committee of 
the Faculty of Biomedical Sciences of the KU Leuven. 
 
Contrast-enhanced nanofocus computed tomography (CE-nanoCT) 
To enable CE-nanoCT from the four mouse knee joint groups samples were processed as 
described in Kerckhofs et al.
[20]
. Briefly, the knee joint capsules were dislocated to expose the 
tibial and femoral cartilage layers. Subsequently, all joints were immersed for 30 minutes in a 
solution of Hexabrix® 320 diluted 4/5 in PBS, were then wrapped in parafilm and were stably 
positioned in the nanoCT system. As the negatively charged ioxaglate of which Hexabrix® 
320 is partially composed, will be locally repelled by the anionic glycosaminoglycans (sGAG) 




The nanoCT system applied in this study was a Phoenix NanoTom S [GE Measurement and 
Control Solutions, Germany]. It was equipped with a tungsten target and was operated, for all 
scans, at a voltage of 60 kV and a current of 140 µA. A 1 mm filter of aluminum was used. 
The exposure time was 500 ms and a frame averaging of 1 and image skip of 0 was applied, 
resulting in a scanning time of 20 minutes per sample. Reconstruction was performed using 
Phoenix datos|x CT software. The isotropic voxel size of all scans was 2 µm. 
 
3D image visualization and analysis 
As described in Kerckhofs et al.
[20]
, to quantify the 3D characteristics of the non-calcified and 
underlying calcified cartilage layers, the cartilage region was selected using CTAn software 
[Bruker micro-CT, Kontich, Belgium] by manually drawing a consistent region of interest 
(ROI) in every 20
th
 cross-section throughout the whole tibial plateau. Briefly, delineating the 
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total cartilage area (i.e. both non-calcified and calcified) was performed based on (i) the 
difference in grey-scale between the non-calcified cartilage and the surrounding (i.e. liquid) 
and (ii) the difference in structure compared to the subchondral bone and non-calcified 
cartilage for the calcified cartilage (i.e. having a porous structure). The ROI was automatically 
interpolated for the 19 intermediate cross-sections. After automatic Otsu segmentation
[23]
, the 
non-calcified and calcified cartilage were segmented and analyzed in 3D by calculating the 
volume, the thickness distribution
[24]
 and the average thickness. Dataviewer [Bruker micro-
CT, Kontich, Belgium] was used on the CE-nanoCT images to perform the modified Mankin 
scoring for cartilage structure and quality, as well as to quantify the loss in sGAG content. 
 
Histology 
After CE-nanoCT imaging, a set of representative knee joints were processed for histology. 
They were fixed in 10 % formalin, decalcified in 4 % formic acid, and embedded in paraffin. 
Sections of 5 µm were made every 60 µm and were stained with Safranin-O and 
counterstained with Fast Green. 
 
Modified Mankin scoring 
The medial side of the tibial plateau in the histological sections (n = 10 per joint) and coronal 
CE-nanoCT images (n = 10 with a 60 µm interspacing) was graded using a modified Mankin 
scoring system
[8]
 specifically for cartilage structure and quality. In brief, for both the 
histological sections and the CE-nanoCT images, articular cartilage structure was graded from 
0 to 11. Concerning the cartilage quality, the Safranin-O staining for the histological sections, 
and the Hexabrix® staining for the CE-nanoCT images were graded between 0 and 8. For 
both parameters, grade 0 represented normal/healthy cartilage. A grade of 11 for the cartilage 
structure was indicative for clefts/loss of articular cartilage extending into the subchondral 
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bone. Grade 8 for cartilage quality implied a severe loss in Safranin-O staining in more than 
half of the depth of the non-calcified cartilage thickness and involving more than half of the 
plateau. Grades of each sample (n = 10) were averaged and summed for the 2 scoring 
parameters, whereby 0 represented completely unaffected hyaline cartilage and the  maximum 
Mankin score of 19 represented a highly degenerated OA knee. 
 
Quantification of the normalized sGAG content 
To quantify the sGAG content in the hyaline cartilage, the intensity of the Hexabrix® 
excluded signal in the non-calcified layer of the hyaline cartilage was normalized to the signal 
of the growth plate cartilage (i.e. in the same coronal CE-nanoCT cross-sections). Hereto, a 
greyscale histogram was plotted along an arbitrary 600 µm line through the non-calcified 
cartilage on the medial side of the tibial plateau (Fig. 1a). The normalized sGAG content in 
the cartilage compared to the healthy growth plate cartilage was then calculated according to 
equation 1. The normalized sGAG content was measured in the same coronal CE-nanoCT 
cross-sections as used for the modified Making scoring. 
                
       
     
           eq. 1 
with CART the average greyscale value (Fig. 1b) along an arbitrary line through the non-
calcified cartilage on the medial side of the tibial plateau (Fig. 1a), BG the average greyscale 
value (Fig. 1d) along a 600 µm long line through the background in the same image (i.e. 
liquid – Fig. 1c-1) and GP the average greyscale value (Fig. 1e) along a 400 µm long line 
through the growth plate cartilage in the same image (Fig. 1c-2). 
 
Partial least square regression modeling 
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In this study, a computational model was used to determine whether a combined set of 
morphological cartilage characteristics could quantitatively and in 3D predict the level of 
cartilage damage in a comparative manner to histological cartilage pathology scoring (using 
the modified Mankin scoring as a measure for cartilage structure and quality). A linear 
modeling formalism was used that was already shown to be capable of relating quantitative 
contributions of multiple signals to a (single) measured response
[25-27]
, namely Partial Least 
Square Regression (PLSR). PLSR is able to identify the information content within the set of 
measured characteristics that most closely maps onto the output response (i.e. modified 
Mankin score). The resulting mapping of lumped signals to corresponding responses allowed 
to identify the most “important structural cartilage characteristics” predictive for the level of 
the cartilage damage. PLSR uses linear algebra to reduce the dimensionality of multivariate 
data sets by defining principle component (PC) axes from the original data set that contain the 
most important information on a specific output variable
[28]
.  For the optimization of the 
number of model dimensions, the root-mean-squared error (RSME) between the measured 
level of cartilage damage and the level predicted by PLSR models with increasing numbers of 
principal components was investigated. Each cartilage characteristic was individually 
withheld from the training set to construct a cross-validation model, in which an RMSE of the 
prediction could be assessed by predicting the withheld sample. The predicted RMSE was 
minimal in this study when using two principal components. To generate the PLSR model, the 
software package JMP® 8 [SAS Institute Inc., NC] was used. 
 
Statistical analysis 
Statistical analysis was done using a statistical software add-in for Microsoft® Excel® for 
Windows, namely Analyse-it version 2.26 Excel 12+. To evaluate the significance level 
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between the groups, one-way ANOVA tests were used with a confidence level of 95 %. All 




CE-nanoCT images are equivalent to histological sections for the modified Mankin scoring 
In Kerckhofs et al.
[20]
, it was already shown that CE-nanoCT has similar discriminative power 
as histology with Safranin-O staining to differentiate bone, non-calcified and calcified 
cartilage in mouse knee joints, and to identify and assess local alterations in cartilage sGAG 
content (i.e. a decrease in sGAG content versus chondral lesions).  
To validate the potency of the CE-nanoCT images  to be used for the modified Mankin scores, 
i.e. the golden standard for histological assessment with Safranin-O staining, these scores 
were determined on the histological sections as well as on the CE-nanoCT coronal sections 
(Fig. 2a). Since full histological scoring was only performed on animals that were not imaged 
by CE-nanoCT, no comparison for the same animal was possible. However, figure 2a shows 
that, within one treatment group, there were no significant differences between the histology-
based and the CE-nanoCT-based scoring for cartilage structure. This supports the equivalence 
of CE-nanoCT images to Safranin-O stained histological sections for modified Mankin score 
determination. The apparent difference between both scores was rather a result of the large 
variability in manifestations of the symptoms between different animals within one treatment 
group. 
The modified Mankin subscore for the cartilage structure on the 2D CE-nanoCT images, as 
well as the sum of the cartilage structure and quality (Fig. 2b), showed significant differences 
between the AM group and the animals that had undergone a DMM procedure (i.e. DMM and 
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DMM/HA), as well as between the sham-operated group and the group that had received a 
two-fold injection of hyaluronic acid after DMM (i.e. DMM/HA). This indicates that for the 
four different groups, having a broad spectrum of cartilage defects (i.e. from bad in case of the 
DMM group to almost unaffected for the AM and sham-operated groups), CE-nanoCT 
provides valid readouts over this whole range, thus showing the potency of CE-nanoCT to be 
implemented as a standard technique for evaluation and quantification of cartilage damage in 
the OA field. 
Next, instead of visually scoring in a semi-quantitative way the degree of non-calcified 
cartilage staining in the CE-nanoCT images, as was done for the modified Mankin subscore 
for cartilage quality, the normalized sGAG loss was quantified by image analysis on the same 
images (Fig. 2c). Every data point in figure 2c represents one CE-nanoCT image. For the 
DMM group, CE-nanoCT images with both a low and a high modified Mankin scoring (and 
sGAG loss) were present and could be distinguished. Although a strong correlation (R² = 
0.79) was found between this analysis and the cartilage quality score, the latter sometimes 
varied for the same percentage of normalized sGAG loss. Moreover, for the same cartilage 
quality score, a range in percentage of normalized sGAG loss was found, thus showing the 
higher sensitivity of the quantification of the normalized sGAG loss by CE-nanoCT image 
analysis compared to the modified Mankin scoring for cartilage quality. When plotting the 
averaged modified Mankin score per animal (n = 10), an even higher correlation was found 
(R² = 0.92). Within the DMM group some animals had a high modified Mankin scoring (and 
sGAG loss), while there is one animal that had a modified Mankin scoring (and sGAG loss) 
comparable to animals in the SHAM and DMM/HA groups. CE-nanoCT scoring thus allows 
not only to discriminate intact versus highly damaged cartilage (fig. 2c), but also to detect 




CE-nanoCT allows 3D quantification of the cartilage structure at the subtissue level 
The in vivo medial meniscus destabilization, which serves as a model for OA
[21]
, is 
characterized by cartilage lesions of various degrees of severities on the medial side (Figs. 3a 
to 3c). As shown in Kerckhofs et al.
[20]
, creating 3D CE-nanoCT models of the different 
cartilaginous layers allowed a straightforward quantification of the defects.  
While no significant differences were found between the different groups for both calcified 
cartilage volume (Fig. 4a) and average thickness of the calcified cartilage (Fig. 4b), the 
overlying non-calcified hyaline cartilage showed significant differences between the DMM 
group and all other groups. 
The averaged thickness distribution plots (n = 3 or 4 per group) of non-calcified and 
calcified cartilage (Figs. 5a and 5b respectively) showed similar findings. For the calcified 
cartilage thickness, the distribution plots for all different treatment groups coincided, and the 
distribution maxima were not significantly different (Fig. 5c). The non-calcified cartilage 
thickness of the DMM group displayed a wide spread distribution with a higher frequency of 
small thicknesses compared to the other groups (Fig. 5a), reflecting a higher presence of 
thinner cartilage (in particular lesions) and loss of sGAGs throughout the non-calcified 
cartilage. Consequently, the „maximum of the distribution‟-plot for the AM group was 
significantly different compared to the other groups. 
 
3D cartilage characteristics determined by CE-nanoCT are predictive for the cartilage 
function and structure 
In order to determine whether a specific combination of quantitative 3D structural and quality 
cartilage parameters could quantitatively predict the severity of cartilage damage as 
determined by the modified Mankin scoring for cartilage structure and quality, a PLSR model 
was developed. The resulting two-component PLRS model was used to examine the 
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correlation between the measured modified Mankin score, as was assessed by multiple 
blinded readers on histological sections, and the predictions for each 3D cartilage parameter 
(Fig. 6a and 6b). The PLSR model combined the (i) non-calcified hyaline cartilage volume, 
(ii) maximum of the non-calcified cartilage thickness distribution and (iii) averaged 
normalized sGAG loss (Fig. 6c). A high predictability of 90.26 % was obtained for the model. 
Including more measured characteristics (e.g. total cartilage volume (i.e. non-calcified and 
calcified cartilage), average thickness of the total cartilage layer, and calcified cartilage 
volume and average thickness) led to a lower predictability of the model due to inclusion of 
irrelevant information (noise).  Inclusion of less measurement characteristics than the three 




Current diagnostics for OA usually do not discover the disease until it is in advanced stages 
when joint damage may already have occurred and the patient presents himself with pain. A 
method for early diagnosis could open a window of opportunity for prevention, thereby 
reducing further damage. Measuring subtle alterations in cartilage structure and quality is 
equally needed to evaluate the (pre)clinical efficacy of new treatment options for cartilage 
damage. Small animal models of OA are hereto essential and thus quantitative readouts with 
functional relevance are key for advancing skeletal research. Nowadays, preclinical efficacy 
of novel therapies for cartilage repair in small animal models is still commonly assessed by 
histopathology, and quantified by using scoring systems such as the modified Mankin scoring. 
Such scoring systems are already in clinical use to assess the severity of the cartilage damage. 





remains a visual, subjective and non-quantitative scoring approach and might not allow to 
distinguish small differences in therapeutic response because of the restricted 2D character. 
As demonstrated in Kerckhofs et al.
[20]
, CE-nanoCT provides equivalent images compared 
to Safranin-O staining on histological sections, with a high contrast between non-calcified and 
calcified cartilage. In this study, we have shown that this allows performing the modified 
Mankin scoring also on CE-nanoCT images of a murine knee joint, which can be assessed 
immediately as it avoids time-consuming and destructive histoprocessing steps, such as 
decalcification, embedding or sectioning, which may take several weeks or, for larger species, 
even months. Moreover, CE-nanoCT generates much more sections throughout the tibial 
plateau than histology and allows objective and quantitative scoring. Grayscale quantification 
of the non-calcified cartilage has shown a good correlation with the modified Mankin scoring 
for cartilage quality, with the advantage of being user-independent and quantitative. Although 
in this study the calculation of the normalized sGAG content was still limited to manual 
image analysis, by implementation of more sophisticated image analysis algorithms this could 
evolve towards a semi-automated tool. Therefore, CE-nanoCT is a valuable tool for virtual 
histopathology. It has to be mentioned that, when the non-calcified cartilage is fully depleted 
of sGAGs, the CE-nanoCT images might not allow to detect the difference with a cartilage 
lesion, and histological sectioning might be required. However, as shown by the quantitative 
measurements of the sGAG loss based on the Hexabrix® staining, very low concentrations of 
sGAGs can still be discriminated from the conditions where cartilage is absent or fully 
depleted of sGAGs. Additionally, CE-nanoCT does not allow yet to visualize the cartilage at 
the cellular level. When this information is required, histological sectioning needs to be 
performed. 
CE-nanoCT also allows, because of its 3D character, analyzing different morphological 
parameters of the bone-cartilage unit
[20]
. Although many studies have used EPIC-CT (i.e. 
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equilibrium partitioning of an ionic contrast agent via microCT) images to quantify 3D 
cartilage parameters
[13-15, 19]
, their correlation to validated histopathological scoring techniques 
has not been shown. Nor has it been shown which of the measured 3D cartilage parameters 
should be included to correlate with validated histological scores. In this study, we have 
shown, using PLSR modeling, that a limited set of easily quantifiable 3D morphological 
parameters (volume and maximum thickness of the non-calcified cartilage and the averaged 
normalized sGAG loss) is predictive for the MM scoring of the cartilage structure and quality. 
These 3D parameters are thus minimally required to draw conclusions on the severity of the 
damage of the articular cartilage in the knee joint. The model could potentially replace the 
MM scoring based on visual inspection as the latter does not involve any quantification of 
cartilage quality or structure. The 3D measurements give more information on size and shape 
(and thus severity) of the cartilage damage compared to 2D histopathology. 
In this study, the analysis of the underlying subchondral bone was not included. However, 
as microCT images (and thus also CE-nanoCT) do allow for this quantification
[5, 7]
, including 
these analyses in the PLSR model could even enhance the correlation of the CE nanoCT 
analysis with the gold standard MM scoring above 90 %. 
Finally, this study assessed four treatment groups using CE-nanoCT that were selected 
because they serve in many studies as control groups to assess the efficacy of a cell therapy 
for cartilage repair, and they represent a broad range of cartilage defects (i.e. from bad to 
unaffected). Mice with a destabilized meniscus displayed lesions with different degrees of 
severity and loss in sGAG content. Two-fold injection of hyaluronic acid after DMM 
(DMM/HA) was proven to be a valid positive control group for this model and follow-up 
period, since the cartilage characteristics, both determined in 2D and 3D, were similar to the 
ones of non-operated or sham-operated animals. CE-nanoCT-based virtual histopathology and 
3D morphological quantification of a limited set of 3D cartilage parameters allowed to 
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distinguish the four groups, and thus is a valid tool to be implemented as a standard technique 
for the evaluation and quantification of cartilage damage in the OA field. 
 
Conclusions 
This study has shown the potential of a non-invasive 3D imaging methodology, namely CE-
nanoCT, for virtual 3D histopathology as it provides images equivalent to Safranin-O stained 
histological sections of murine knee joints. Because of its non-invasive and 3D character, and 
because it reveals differences in structure and composition between calcified, non-calcified 
cartilage and the underlying bone in small animal models with high spatial and contrast 
resolution, CE-nanoCT provides faster and more quantitative data on cartilage structure and 
quality compared to standard histopathology. Moreover, it was shown that a limited set of 
these quantitative 3D measures is able to reproduce the standard histopathological scoring, 
with the advantage of being user-independent and semi-automated, thus being a potential 
replacement of the histopathological scoring. To conclude, CE-nanoCT has demonstrated its 
equivalency to standard histopathology in preclinical small animal studies addressing 
cartilage-related pathologies and therapeutic interventions. 
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Figure 1. (a) A typical coronal CE-nanoCT image and (b) the corresponding greyscale 
histogram along the white line drawn in (a) through the non-calcified cartilage on the medial 
(left) side of the tibial plateau (grey curve) with the average greyscale value (black curve). (c) 
A typical coronal CE-nanoCT image and (d, e) the corresponding greyscale histograms (d) 
along the white line annotated with „1‟ drawn in (c) through the background of the image 
(grey curve) with the average greyscale value (black curve) and (e) along the white line 
annotated with „2‟ drawn in (c) through the growth plate cartilage (grey curve) with the 
average greyscale value (black curve). 
 
Figure 2. (a) The modified Mankin (MM) scoring for the cartilage structure, determined on 
histological and CE-nanoCT sections for the different treatments groups. The animals used for 
the histological scoring (n = 3 or 4 per group) were not the same individuals that than the ones 
assessed by the CE-nanoCT scoring (n = 3 or 4 per group). (b) The MM scoring of 2D CE-
nanoCT images. The score for the cartilage structure only and the sum for cartilage structure 
and quality are shown for the different treatments groups. (c) Correlation plot between the 
percentage of sGAG loss normalized to the growth plate cartilage and the MM scoring for the 
cartilage quality (as measured by Hexabrix® staining intensity), both determined on the 
individual 2D sectional CE-nanoCT images throughout the different treatments groups and (d) 
the same correlation plot as (c) but the % sGAG loss and MM score were averaged over all 
scored sections of each animal (n = 10). 
 
Figure 3. A representative (a) cross-sectional, (b) coronal and (c) sagittal CE-nanoCT image 
of a tibial plateau of a mouse of which 8 weeks in vivo meniscus destabilization (DMM) 




Figure 4. (a) The volume and (b) average thickness of non-calcified and calcified cartilage on 
the medial tibial plateau of the 4 different treatments groups (n = 3 or 4) [
a
 p < 0.05 = 
significantly different], based on quantitative analysis of 3D CE nanoCT images. The data for 




Figure 5. The (a) non-calcified and (b) underlying calcified cartilage thickness distribution on 
the medial tibial plateau of the different treatments groups (n = 3 or 4). The data for the Sham 
and DMM group have already been presented in Kerckhofs et al.
[20]
. (c) The „maximum of the 
thickness distribution‟-plot averaged per animal group (n = 3 or 4), both for the non-calcified 
and calcified cartilage layers [
a
 p < 0.05 = significantly different]. 
 
Figure 6. (a) The measured MM score versus the cross-validated predictions for each 3D 
cartilage parameter, (b) the residuals for the cross-validated predictions and (c) the 3 3D 
cartilage parameters of which the PLSR model is composed, resulting in the following 
predictive equation: MM scoring = 3.55 + 33.70*(non-calcified cartilage volume in mm³) – 
0.0375*(maximum of the non-calcified cartilage thickness distribution plot in µm) + 
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